Table 2 Adjusted odds ratios (ORs) of having NTproBNP levels above median value (34 pg/ml) in people aged 45–74 years in the population-based Casale Monferrato Study
| Â | Adjusted OR* (95% CI) |
|---|---|
Model 1 | |
 BMI < 25 kg/m2 | 1.00 |
 BMI ≥ 25 kg/m2 | 0.70 (0.56–0.87) |
 Non diabetes | 1.00 |
 Diabetes | 2.60 (2.37–2.87) |
 People without CVD | |
   BMI < 25 kg/m2 | 1.00 |
   BMI ≥ 25 kg/m2 | 0.67 (0.53–0.86) |
   Non diabetes | 1.00 |
   Diabetes | 2.47 (2.23–2.74) |
Model 2 | |
 Non diabetes, BMI < 25 kg/m2 | 1.00 |
 Non diabetes, BMI ≥ 25 kg/m2 | 0.63 (0.48–0.82) |
 Diabetes, BMI < 25 kg/m2 | 5.44 (3.98–7.44) |
 Diabetes, BMI ≥ 25 kg/m2 | 4.42 (3.25–6.01) |
 P for trend | < 0.0001 |
 People without CVD | |
  BMI < 25 kg/m2 | 1.00 |
  BMI ≥ 25 kg/m2 | 0.64 (0.48–0.88) |
  Non diabetes | 5.47 (3.93–7.62) |
  Diabetes | 4.13 (2.99–5.72) |
  P for trend | < 0.0001 |
Model 3 | |
 Neither Metabolic syndrome nor diabetes | 1.00 |
 Metabolic syndrome | 1.67 (1.25–2.22) |
 Diabetes | 7.45 (5.54–10.01) |
 Metabolic syndrome + diabetes | 7.56 (5.84–9.78) |
 P for trend | < 0.0001 |
 People without CVD | |
  Neither Metabolic syndrome nor diabetes | 1.00 |
  Metabolic syndrome | 1.99 (1.48–2.69) |
  Diabetes | 7.49 (5.47–10.3) |
  Metabolic syndrome + diabetes | 7.52 (5.70–9.92) |
  P for trend | < 0.0001 |